It looks like this podcast has ended some time ago. This means that no new episodes have been added some time ago. If you're the host of this podcast, you can check whether your RSS file is reachable for podcast clients.
Medicine Matters oncology
by Springer HealthcareInterviews with clinical experts, discussing key issues in oncology.
Copyright: Springer Healthcare, part of the Springer Nature group
Episodes
COVID-19 vaccination in patients with cancer (with Narjust Duma)
11m · PublishedWe speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as vaccine timing, side-effects, and key unanswered research questions.
Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)
24m · PublishedIn this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials.
Find more on Medicine Matters oncology
The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee)
7m · PublishedCo-project leader Lennard Lee talks about the inception and development of the initiative that will provide insight into the impact of COVID-19 on people with cancer and facilitate shared learning that will benefit patient care.
Find more on Medicine Matters oncology
CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)
5m · PublishedGilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making.
Find more on Medicine Matters oncology
Image credit: © koto_feja/Getty Images/iStock
COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy)
26m · PublishedThoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as telemedicine are coming into their own.
Find more on Medicine Matters oncology
Image credit: Coronavirus illustration © dottedyeti/stock.adobe.com
Managing patients with genitourinary cancers in the time of COVID-19 (with Cora Sternberg)
11m · PublishedGenitourinary oncologists Cora Sternberg (Weill Cornell Medicine, New York, USA) and Axel Merseburger (University Hospital Schleswig-Holstein, Lübeck, Germany) share their experience of managing cancer patients during the COVID-19 pandemic, comparing perspectives from a US and German stand point.
Find more on Medicine Matters oncology
COVID-19 and cancer patient care: A lung cancer specialist’s experience (with Gilberto Lopes)
5m · PublishedGilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemented to minimize the risk for patients.
Find more on Medicine Matters oncology
Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)
3m · PublishedColin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation – in patients with locally advanced or metastatic non-small-cell lung cancer.
Find more on Medicine Matters oncology
More from WCLC 2019
Understanding the relationship between the gut microbiome and immunotherapy (with Jennifer Wargo)
13m · PublishedRecent research has shown an association between intestinal microbiota and response to immunotherapy in the setting of various tumor types. Listen to Jennifer Wargo, from The University of Texas MD Anderson Cancer Center in Houston, USA, share her insights into the findings.
Find more on Medicine Matters oncology
This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on January 28, 2019.
Researcher comment: COMPARE study (with Hashim Ahmed)
5m · PublishedHashim Ahmed takes us through the COMPARE study – presented at NCRI 2018 – which showed that men with localized prostate cancer are willing to accept lower survival odds for a better quality of life. He outlines the key findings, the implications of the results for physicians, and the next steps for research.
Find more on Medicine Matters oncology
This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on November 15, 2018.
Medicine Matters oncology has 14 episodes in total of non- explicit content. Total playtime is 2:39:00. The language of the podcast is English. This podcast has been added on December 24th 2022. It might contain more episodes than the ones shown here. It was last updated on March 24th, 2024 02:20.
